Cargando…

Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection

BACKGROUND: Urine LAM testing has been approved by the WHO for use in hospitalised patients with advanced immunosuppression. However, sensitivity remains suboptimal. We therefore examined the incremental diagnostic sensitivity of early morning urine (EMU) versus random urine sampling using the Deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gina, Phindile, Randall, Philippa J., Muchinga, Tapuwa E., Pooran, Anil, Meldau, Richard, Peter, Jonny G., Dheda, Keertan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429506/ https://www.ncbi.nlm.nih.gov/pubmed/28499418 http://dx.doi.org/10.1186/s12879-017-2313-0

Ejemplares similares

The Diagnostic Accuracy of Urine-Based Xpert MTB/RIF in HIV-Infected Hospitalized Patients Who Are Smear-Negative or Sputum Scarce
por: Peter, Jonathan G., et al.
Publicado: (2012)

Same-Day Tools, Including Xpert Ultra and IRISA-TB, for Rapid Diagnosis of Pleural Tuberculosis: a Prospective Observational Study
por: Meldau, Richard, et al.
Publicado: (2019)

Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments
por: Theron, Grant, et al.
Publicado: (2014)

Can Point-of-Care Urine LAM Strip Testing for Tuberculosis Add Value to Clinical Decision Making in Hospitalised HIV-Infected Persons?
por: Peter, Jonathan G., et al.
Publicado: (2013)

Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing
por: Peter, Jonny, et al.
Publicado: (2015)

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies
por: Lawn, Stephen D, et al.
Publicado: (2013)

The diagnostic accuracy of pericardial and urinary lipoarabinomannan (LAM) assays in patients with suspected tuberculous pericarditis
por: Pandie, Shaheen, et al.
Publicado: (2016)

Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples
por: Dheda, Keertan, et al.
Publicado: (2010)

Diagnosis of COVID-19: Considerations, Controversies and Challenges in South Africa
por: Dheda, Keertan, et al.
Publicado: (2020)

The Injectable Contraceptive Medroxyprogesterone Acetate Attenuates Mycobacterium tuberculosis–Specific Host Immunity Through the Glucocorticoid Receptor
por: Tomasicchio, Michele, et al.
Publicado: (2019)

Economic evaluation of microbiological and host biomarker-based tests for the diagnosis of pleural tuberculosis in a high burden setting
por: Pooran, Anil, et al.
Publicado: (2022)

What is the Cost of Diagnosis and Management of Drug Resistant Tuberculosis in South Africa?
por: Pooran, Anil, et al.
Publicado: (2013)

The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report
por: Davids, Malika, et al.
Publicado: (2021)

Correlation of Mycobacterium Tuberculosis Specific and Non-Specific Quantitative Th1 T-Cell Responses with Bacillary Load in a High Burden Setting
por: Theron, Grant, et al.
Publicado: (2012)

Psychological distress and its relationship with non-adherence to TB treatment: a multicentre study
por: Theron, Grant, et al.
Publicado: (2015)

An autologous dendritic cell vaccine polarizes a Th-1 response which is tumoricidal to patient-derived breast cancer cells
por: Tomasicchio, Michele, et al.
Publicado: (2018)

Reproducibility of urinary phthalate metabolites in first morning urine samples.
por: Hoppin, Jane A, et al.
Publicado: (2002)

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

Clinical Diagnostic Utility of IP-10 and LAM Antigen Levels for the Diagnosis of Tuberculous Pleural Effusions in a High Burden Setting
por: Dheda, Keertan, et al.
Publicado: (2009)

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV
por: Boyles, Tom H., et al.
Publicado: (2018)

Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study
por: Meldau, Richard, et al.
Publicado: (2014)

Selection and Application of ssDNA Aptamers to Detect Active TB from Sputum Samples
por: Rotherham, Lia S., et al.
Publicado: (2012)

Diagnostic Accuracy of Lateral Flow Urine LAM Assay for TB Screening of Adults with Advanced Immunosuppression Attending Routine HIV Care in South Africa
por: Hanifa, Yasmeen, et al.
Publicado: (2016)

User perspectives and preferences on a novel TB LAM diagnostic (Fujifilm SILVAMP TB LAM)–a qualitative study in Malawi and Zambia
por: Herrmann, Yannis, et al.
Publicado: (2022)

Uptake of the lateral flow urine LAM test in Europe and Central Asia
por: Kraef, C., et al.
Publicado: (2022)

Comparison of a Clinical Prediction Rule and a LAM Antigen-Detection Assay for the Rapid Diagnosis of TBM in a High HIV Prevalence Setting
por: Patel, Vinod B., et al.
Publicado: (2010)

Association of anti-tuberculosis drug concentrations in hair and treatment outcomes in MDR- and XDR-TB
por: Metcalfe, John, et al.
Publicado: (2019)

Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
por: Sabur, Natasha F., et al.
Publicado: (2017)

Video Q&A: Rapid urine LAM test for HIV-associated TB - potential to reduce deaths? An interview with Stephen Lawn
por: Lawn, Stephen D
Publicado: (2013)

Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications
por: Lawn, Stephen D., et al.
Publicado: (2016)

“SILVAMP TB LAM” Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa
por: Sossen, Bianca, et al.
Publicado: (2020)

Proteinase K-pretreated ConA-based ELISA assay: a novel urine LAM detection strategy for TB diagnosis
por: Huang, Huan, et al.
Publicado: (2023)

Evaluating Latent Tuberculosis Infection Test Performance Using Latent Class Analysis in a TB and HIV Endemic Setting
por: Adams, Shahieda, et al.
Publicado: (2019)

Fujifilm SILVAMP TB-LAM for the Diagnosis of Tuberculosis in Nigerian Adults
por: Comella-del-Barrio, Patricia, et al.
Publicado: (2021)

Systematic, Point-of-Care Urine Lipoarabinomannan (Alere TB-LAM) Assay for Diagnosing Tuberculosis in Severely Immunocompromised HIV-Positive Ambulatory Patients
por: Huerga, Helena, et al.
Publicado: (2020)

Performance of Tuberculosis Molecular Bacterial Load Assay Compared to Alere TB-LAM in Urine of Pulmonary Tuberculosis Patients with HIV Co-Infections
por: Mapamba, Daniel Adon, et al.
Publicado: (2023)

Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis
por: Pooran, Anil, et al.
Publicado: (2010)

Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis
por: Comella-del-Barrio, Patricia, et al.
Publicado: (2021)

Clinical Efficacy of Moringa oleifera Lam. Stems Bark in Urinary Tract Infections
por: Maurya, Santosh Kumar, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e3egal7m0i8iu7sr8ce00mltk9